John Ling

2.0k total citations · 1 hit paper
50 papers, 1.1k citations indexed

About

John Ling is a scholar working on Infectious Diseases, Molecular Biology and Agronomy and Crop Science. According to data from OpenAlex, John Ling has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 10 papers in Molecular Biology and 10 papers in Agronomy and Crop Science. Recurrent topics in John Ling's work include HIV/AIDS drug development and treatment (13 papers), Ruminant Nutrition and Digestive Physiology (10 papers) and HIV Research and Treatment (6 papers). John Ling is often cited by papers focused on HIV/AIDS drug development and treatment (13 papers), Ruminant Nutrition and Digestive Physiology (10 papers) and HIV Research and Treatment (6 papers). John Ling collaborates with scholars based in United States, United Kingdom and Japan. John Ling's co-authors include P. J. Buttery, Anita Mathias, Ian Armstead, Polina German, Huyen Cao, Anu Osinusi, Rita Humeniuk, Brian P. Kearney, Justin D. Lutz and Brian J. Kirby and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Applied and Environmental Microbiology.

In The Last Decade

John Ling

47 papers receiving 1.1k citations

Hit Papers

Pharmacokinetics and safety of once-yearly lenacapavir: a... 2025 2026 2025 4 8 12

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Ling United States 16 347 223 217 159 137 50 1.1k
Myron A. Holscher United States 20 282 0.8× 108 0.5× 178 0.8× 164 1.0× 138 1.0× 48 1.6k
Subhash Dhawan United States 22 286 0.8× 38 0.2× 741 3.4× 182 1.1× 125 0.9× 56 1.8k
Akbar Ali Pakistan 21 205 0.6× 76 0.3× 211 1.0× 195 1.2× 257 1.9× 100 1.4k
Kuldeep Sharma India 18 311 0.9× 61 0.3× 116 0.5× 71 0.4× 73 0.5× 72 884
Ravindra P. Veeranna India 21 285 0.8× 53 0.2× 623 2.9× 462 2.9× 198 1.4× 48 1.9k
Holly L. Jordan United States 17 124 0.4× 51 0.2× 171 0.8× 322 2.0× 73 0.5× 43 985
Xing Wu China 27 676 1.9× 252 1.1× 721 3.3× 434 2.7× 145 1.1× 93 2.1k
Mária Mareková Slovakia 19 81 0.2× 93 0.4× 401 1.8× 143 0.9× 66 0.5× 113 1.3k
Ling Wang China 25 575 1.7× 50 0.2× 432 2.0× 328 2.1× 101 0.7× 96 1.8k

Countries citing papers authored by John Ling

Since Specialization
Citations

This map shows the geographic impact of John Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Ling more than expected).

Fields of papers citing papers by John Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Ling. The network helps show where John Ling may publish in the future.

Co-authorship network of co-authors of John Ling

This figure shows the co-authorship network connecting the top 25 collaborators of John Ling. A scholar is included among the top collaborators of John Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Ling. John Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arora, Priyanka, et al.. (2025). Clinical Evaluation of Drug–Drug Interactions Between Bictegravir and Strong Inhibitors/Inducers of the CYP3A4, UGT1A1, or P‐gp Pathways. The Journal of Clinical Pharmacology. 65(11). 1420–1432.
2.
Ling, John, et al.. (2025). Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study. The Lancet. 405(10485). 1147–1154. 14 indexed citations breakdown →
4.
Odegard, Jared, Ahmed A. Othman, Kai-Wen Lin, et al.. (2024). Oral PD-L1 inhibitor GS-4224 selectively engages PD-L1 high cells and elicits pharmacodynamic responses in patients with advanced solid tumors. Journal for ImmunoTherapy of Cancer. 12(4). e008547–e008547. 8 indexed citations
5.
Subramanian, Raju, John Ling, Jianhong Wang, et al.. (2022). Human and nonclinical disposition of [14C]bictegravir, a potent integrase strand-transfer inhibitor for the treatment of HIV-1 infection. Xenobiotica. 52(9-11). 973–985. 4 indexed citations
6.
Humeniuk, Rita, Anita Mathias, Brian J. Kirby, et al.. (2021). Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor. Clinical Pharmacokinetics. 60(5). 569–583. 93 indexed citations
7.
Begley, Rebecca, Moupali Das, Lijie Zhong, et al.. (2018). Pharmacokinetics of Tenofovir Alafenamide When Coadministered With Other HIV Antiretrovirals. JAIDS Journal of Acquired Immune Deficiency Syndromes. 78(4). 465–472. 37 indexed citations
8.
Zheng, Jim, Xin Yan, Jingyu Zhang, et al.. (2018). Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite—Resolution for Clinical Development. Drug Metabolism and Disposition. 46(3). 237–247. 40 indexed citations
9.
Zhang, Heather, Joseph M. Custodio, Xuelian Wei, et al.. (2017). P176 Clinical pharmacology of the HIV integrase strand transfer inhibitor bictegravir. Sexually Transmitted Infections. 93(Suppl 1). A74.2–A74. 10 indexed citations
10.
Staskin, David, Gary G. Kay, Cara Tannenbaum, et al.. (2010). Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder. International Journal of Clinical Practice. 64(9). 1294–1300. 95 indexed citations
12.
Wabnitz, David, et al.. (2007). Quality of life outcomes after ventilating tube insertion for otitis media in an Australian population. International Journal of Pediatric Otorhinolaryngology. 71(10). 1543–1547. 37 indexed citations
13.
Schieber, Andreas, et al.. (1999). Gc-ms analysis of diaminopimelic acid stereoisomers and amino acid enantiomers in rumen bacteria. Biomedical Chromatography. 13(1). 46–50. 23 indexed citations
14.
Tomita, Yoshifumi, et al.. (1996). Measurement of total and separate stereoisomers of diaminopimelic acid in rumen bacteria by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 677(1). 53–59. 13 indexed citations
15.
Ling, John & Ian Armstead. (1995). The in vitro uptake and metabolism of peptides and amino acids by five species of rumen bacteria. Journal of Applied Bacteriology. 78(2). 116–124. 45 indexed citations
16.
Nagasawa, Takashi, John Ling, & R. Onodera. (1993). Chiral high-performance liquid chromatographic separation of the three stereoisomers of 2,6-diaminopimelic acid without derivatisation. Journal of Chromatography A. 653(2). 336–340. 13 indexed citations
17.
Armstead, Ian & John Ling. (1991). Chromatographic separation of mixed peptides from amino acids in biological digests with volatile buffers. Journal of Chromatography A. 586(2). 259–263. 15 indexed citations
18.
Onodera, R., et al.. (1991). In Vitro Production of Lysine from 2,2′‐Diaminopimelic Acid by Rumen Protozoa. The Journal of Protozoology. 38(4). 421–425. 4 indexed citations
19.
Ling, John, et al.. (1987). Whole animal and rumen digestive parameters of sheep given a concentrate diet supplemented with sodium bicarbonate. Archiv für Tierernaehrung. 37(4). 327–334. 4 indexed citations
20.
Ling, John, H. Swan, & P. J. Buttery. (1983). Interrelationships in the Digestion of Sheep Given Barley Grain Diets Containing Either Fish Meal, Soya-bean Meal or Urea. Archiv für Tierernaehrung. 33(10-11). 793–804. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026